Detalhe da pesquisa
1.
Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer.
Breast Cancer Res
; 22(1): 132, 2020 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256808
2.
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(5): 1105-1115, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36288547
3.
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Neuro Oncol
; 25(2): 339-350, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849035
4.
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.
JTO Clin Res Rep
; 3(1): 100262, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005654
5.
Targeted sonodynamic destruction of glioblastoma cells using antibody-titanium dioxide nanoparticle conjugates.
Nanomedicine (Lond)
; 16(7): 523-534, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660528
6.
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
J Thorac Oncol
; 16(9): 1559-1569, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33652156
7.
Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation.
Mol Cancer Ther
; 19(6): 1328-1339, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32371586
8.
A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers.
Cancer Biol Ther
; 21(6): 549-559, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192391
9.
TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.
Mol Oncol
; 14(1): 54-68, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736230
10.
Use of quantitative immunofluorescence microscopy to study intracellular trafficking: studies of the GLUT4 glucose transporter.
Methods Mol Biol
; 457: 347-66, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19066040
11.
The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking.
Retrovirology
; 3: 62, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16978406
12.
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines.
Anat Cell Biol
; 48(1): 25-35, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25806119
13.
Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.
Mol Biol Cell
; 20(1): 498-508, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18946087
14.
Molecular mechanisms controlling GLUT4 intracellular retention.
Mol Biol Cell
; 19(8): 3477-87, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18550797
15.
GLUT4 is internalized by a cholesterol-dependent nystatin-sensitive mechanism inhibited by insulin.
EMBO J
; 25(24): 5648-58, 2006 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-17139247
16.
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
J Virol
; 80(14): 6844-54, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16809290
17.
Intracellular distribution of human T-cell leukemia virus type 1 Gag proteins is independent of interaction with intracellular membranes.
J Virol
; 76(2): 905-11, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11752179
18.
Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
J Cell Sci
; 117(Pt 17): 3983-93, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15286176
19.
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding.
J Cell Sci
; 117(Pt 11): 2357-67, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15126635